Media Advisory – Interview and Photo Opportunity: Leading Canadian Researchers to Announce Landmark Study Involving …

SOURCE: Multiple Sclerosis Society of Canada

WINNIPEG, MB--(Marketwired - January 23, 2015) - On Thursday, January 29, 2015, the Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation, along with principal investigators Dr. Mark Freedman and Dr. James Marriott, will be announcing a human clinical trial involving a novel stem cell treatment in multiple sclerosis (MS).

Canada has the highest rate of MS in the world. MS is a chronic, often disabling disease of the central nervous system comprising the brain, spinal cord and optic nerve. It is one of the most common neurological diseases affecting young adults in Canada. Most people with MS are diagnosed between the ages of 15 and 40, and the unpredictable effects of MS last for the rest of their lives.

Media are welcome to attend an event at Health Sciences Centre Winnipeg where Mr. Yves Savoie, president and CEO of the MS Society of Canada, and Dr. James Marriott will announce the details of this landmark study.

When:12pm CT, Thursday, January 29, 2015

Interview and photo opportunities will be available with:

Where:Courtyard Caf, Health Sciences Centre Winnipeg Magenta Fox Zone, Level 2 800 Sherbrook St. Winnipeg, Manitoba

Note: The Courtyard Caf is located on the 2nd floor of the Rehabilitation Centre at Health Sciences Centre Winnipeg.

Join the conversation and connect with the MS community online. Find the MS Society on Twitter, Instagram or like our page on Facebook.

View original post here:
Media Advisory - Interview and Photo Opportunity: Leading Canadian Researchers to Announce Landmark Study Involving ...